Jacopo Conforti

ORCID: 0009-0004-2831-2134 · 6 papers in corpus
meta-analysis 2026
Reproduction & fertility ·doi:10.1530/raf-25-0094

ABSTRACT: Endometriosis is a chronic inflammatory disease presenting with debilitating symptoms strongly impacting patients' quality of life (QoL). Assessing QoL is crucial for understanding the full patient experience beyond clinical sympt…

diagnostic-accuracy 2026
Human Reproduction ·doi:10.1093/humrep/deaf221

STUDY QUESTION: Can a serum miRNA signature serve as a potential diagnostic biomarker for endometriosis (END)? SUMMARY ANSWER: A miRNA-based diagnostic model demonstrated an accuracy of 65.8% in distinguishing END patients from control sub…

observational 2025
Biomedicines ·doi:10.3390/biomedicines13102381

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medica…

case-report 2025
Clinical case reports ·doi:10.1002/ccr3.71335

Primary presacral clear cell carcinoma (CCC) of Müllerian origin is extremely rare. Malignant transformation of endometriosis is a known phenomenon, though typically involving the ovaries or pelvic peritoneum. Retroperitoneal presentation, …

diagnostic-accuracy 2025
·doi:10.23736/s0393-0564.25.00034-2

INTRODUCTION: Endometriosis (END) is a debilitating gynecological disorder. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. The discovery of non-invasive biomarkers is necessary to overcome the disa…

observational 2024
Women's health (London, England) ·doi:10.1177/17455057241252573

BACKGROUND: Almost 10% of women in reproductive age are diagnosed with ovarian endometriomas and can experience symptoms and infertility disorders. Ovarian endometriomas can be treated with medical or surgical therapy. OBJECTIVE: To assess…